calendar
31,600 catalysts · 12,072 approval · 5,000 device 510k · 4,728 grant · 3,009 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
31,600 catalysts · 12,072 approval · 5,000 device 510k · 4,728 grant · 3,009 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: CHIESI. Form: CAPSULE. Route: ORAL
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: HERON THERAPS INC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: DIFGEN PHARMS. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: JANSSEN PRODS. Form: POWDER. Route: INTRAVENOUS
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: BAYER. Form: TABLET. Route: ORAL
Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL
Sponsor: REGCON HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: EMULSION. Route: OPHTHALMIC
Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL
Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: CAPSULE. Route: ORAL
Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL
Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL
Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: NOVEN PHARMS INC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL